13F Holdings
中文EN

ACXP Acurx Pharmaceuticals, Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1736243 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY11.7%
TTM EPS YoY76.9%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-147.5%
ROA-98.5%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets29.0%
Debt / equity0.00x
Current ratio—
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.84x
Accruals ratio-15.9%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue—————
R&D expense$1.83M$5.40M$6.04M$4.75M$2.03M
SG&A expense$6.26M$8.72M$8.53M$7.34M$10.78M
Operating income-$8.09M-$14.12M———
Income tax———$0—
Net income-$7.97M-$14.10M-$14.58M-$12.09M-$12.75M
EPS (basic)-5.32-17.45-1.15-1.12-1.49
EPS (diluted)-5.32-17.45-1.15-1.12-1.49
Weighted avg. shares (diluted)1.50M808,16812.67M10.82M8.54M
Balance sheet
Cash & equivalents$7.56M$3.71M$7.47M$9.11M$12.96M
Current assets—$3.86M$7.71M$9.38M$13.25M
Total assets$7.69M$3.86M$7.71M$9.38M$13.25M
Current liabilities$2.42M$3.24M$3.04M$2.06M$843,909
Total liabilities$2.42M$3.24M$3.04M$2.06M$843,909
Shareholders' equity$5.27M$615,121$4.67M$7.32M$12.41M
Shares outstanding2.35M851,53414.47M11.63M10.22M
Cash flow statement
Operating cash flow-$6.79M-$10.38M-$9.80M-$7.54M-$5.01M
Financing cash flow$10.64M$6.62M$8.16M$3.70M$14.80M
Stock-based compensation$1.25M$2.60M$3.21M$2.87M$5.15M

Free plan shows the latest 5 periods; Pro shows all 6 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.